Q1 2026 Centene Corp Earnings Call Transcript
Key Points
- Centene Corp (CNC) reported a strong first quarter with adjusted diluted EPS of $3.37, exceeding expectations.
- The company increased its full-year 2026 adjusted EPS outlook to greater than $3.40, up from the previous expectation of greater than $3.
- Medicaid business showed excellent progress with margin improvement through targeted initiatives.
- Medicare segment results were ahead of expectations, with outperformance from both Medicare Advantage and PDP offerings.
- Centene Corp (CNC) demonstrated strong cash flow from operations, amounting to $4.4 billion for Q1.
- There is a cautious outlook for the remainder of 2026 due to uncertainties in key factors influencing the year.
- The commercial segment faced a slightly higher-than-expected HBR, although it was offset by favorability in SG&A.
- The company is facing elevated trends in behavioral health and high-cost drugs, which continue to impact financials.
- Centene Corp (CNC) anticipates a step down in earnings from Q1 to Q2, with Q3 around breakeven and Q4 at a loss position due to seasonality.
- The company has significant debt maturities coming up in 2027 and 2028, which may require refinancing at higher rates.
Good day, and welcome to the Centene Corporation's 2026 first quarter earnings report. (Operator Instructions)
Please also note today's event is being recorded. I'd now like to turn the conference over to Jennifer Gilligan, Senior Vice President, Investor Relations. Please go ahead.
Thank you, Rocco, and good morning, everyone. Thank you for joining us on our first quarter 2026 earnings results conference call. Sarah London, Chief Executive Officer; and Drew Asher, Executive Vice President and Chief Financial Officer of Centene, will host this morning's call, which also can be accessed through our website at centene.com.
Any remarks that Centene may make about future expectations, plans and prospects constitute forward-looking statements for the purpose of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995. Specifically, our commentary on our full year 2026 outlook, including the drivers of such outlook, are forward-looking statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
